Summary A new mandelic acid derived diamido-diol was synthesised on the base of (1R,2R)-1,2-diaminocyclohexane scaffold and evaluated for its in vitro activity against M. tuberculosis H37Rv. The compound shows activity comparable with the one of the classical anti-TB drug ethambutol.